PL2035006T3 - Zastosowanie allopurynolu do leczenia erytrodyzestezji dłoniowo-podeszwowej - Google Patents

Zastosowanie allopurynolu do leczenia erytrodyzestezji dłoniowo-podeszwowej

Info

Publication number: PL2035006T3
Authority: PL; Poland
Prior art keywords: allopurinol; treatment; plantar erythrodysesthesia; palmar plantar; palmar
Prior art date: 2006-06-01

Application number

PL07729768T

Other languages

English (en)

Inventor

Yolanda Rodemer

Original Assignee

Nobera Pharma Sl

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-06-01

Filing date

2007-05-31

Publication date

2010-07-30

2006-06-01 Priority claimed from EP06011432A external-priority patent/EP1862166A1/en

2007-05-31 Application filed by Nobera Pharma Sl filed Critical Nobera Pharma Sl

2010-07-30 Publication of PL2035006T3 publication Critical patent/PL2035006T3/pl

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Dermatology (AREA)
Toxicology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Pain & Pain Management (AREA)
Biomedical Technology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Saccharide Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

PL07729768T 2006-06-01 2007-05-31 Zastosowanie allopurynolu do leczenia erytrodyzestezji dłoniowo-podeszwowej PL2035006T3 (pl)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
EP06011432A EP1862166A1 (en)	2006-06-01	2006-06-01	Use of allopurinol for the treatment of palmar plantar erythrodysesthesia
EP07107744		2007-05-08
PCT/EP2007/055367 WO2007138103A1 (en)	2006-06-01	2007-05-31	Use of allopurinol for the treatment of palmar plantar erythrodysesthesia
EP07729768A EP2035006B1 (en)	2006-06-01	2007-05-31	Use of allopurinol for the treatment of palmar plantar erythrodysesthesia

Publications (1)

Publication Number	Publication Date
PL2035006T3 true PL2035006T3 (pl)	2010-07-30

Family

ID=38512579

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL07729768T PL2035006T3 (pl)	2006-06-01	2007-05-31	Zastosowanie allopurynolu do leczenia erytrodyzestezji dłoniowo-podeszwowej

Country Status (21)

Country	Link
US (3)	US7973046B2 (pl)
EP (1)	EP2035006B1 (pl)
JP (3)	JP5028480B2 (pl)
KR (1)	KR101471022B1 (pl)
AT (1)	ATE457729T1 (pl)
AU (1)	AU2007267069B2 (pl)
CA (1)	CA2654270C (pl)
CY (1)	CY1110336T1 (pl)
DE (1)	DE602007004849D1 (pl)
DK (1)	DK2035006T3 (pl)
ES (1)	ES2341379T3 (pl)
HR (1)	HRP20100210T1 (pl)
IL (1)	IL195472A (pl)
MX (1)	MX2008015266A (pl)
NZ (1)	NZ573248A (pl)
PL (1)	PL2035006T3 (pl)
PT (1)	PT2035006E (pl)
RS (1)	RS51252B (pl)
RU (1)	RU2438673C2 (pl)
SI (1)	SI2035006T1 (pl)
WO (1)	WO2007138103A1 (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2246057A1 (en) *	2009-04-29	2010-11-03	Nobera Pharma, S.L.	Use of allopurinol for the treatment of hand foot skin reaction
JP2013508295A (ja)	2009-10-16	2013-03-07	デューク・ユニヴァーシティ	薬物誘発性手足症候群を治療するための組成物および方法
EP2368549A1 (en)	2010-03-25	2011-09-28	BioAlliance Pharma	Treating hand-foot syndrome and related pathologies using clonidine or its derivatives
JP4983989B2 (ja) *	2010-03-31	2012-07-25	小野薬品工業株式会社	手足症候群の予防および治療剤
EP2554184B1 (en)	2010-03-31	2016-10-26	ONO Pharmaceutical Co., Ltd.	Preventive and/or remedy for hand and foot syndrome
JP4761000B1 (ja) *	2010-11-08	2011-08-31	小野薬品工業株式会社	手足症候群の予防および／または治療剤
US9259343B2 (en)	2012-07-06	2016-02-16	Newman Technologies LLC	Device for mitigating plantar fasciitis
EP2712613B1 (en) *	2012-09-28	2017-02-08	Pharmadab d.o.o.	Vitamin K1 and uses thereof
HUE054241T2 (hu) *	2016-03-28	2021-08-30	Vidac Pharma Ltd	Stabil gyógyszerkészítmények topikális beadásra és alkalmazásuk
CN111601617A (zh)	2017-12-13	2020-08-28	上海岸阔医药科技有限公司	一种用于预防或治疗与egfr 被抑制相关疾病的方法
JP7520366B2 (ja)	2018-04-16	2024-07-23	オンクオリティーファーマシューティカルズチャイナリミテッド	腫瘍療法の副作用の予防または治療方法
RU2722396C2 (ru) *	2018-07-11	2020-05-29	Федеральное государственное бюджетное учреждение дополнительного профессионального образования "Центральная государственная медицинская академия" Управления делами Президента Российской Федерации (ФГБУ ДПО "ЦГМА")	Способ лечения пальмарно-плантарной эритродизестезии

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3011A (en) *		1843-03-21		Improvement in water-wheels
EP0278040B1 (de)	1987-02-13	1991-08-14	Pharm-Allergan Gmbh	Verwendung von Pteridinen und/oder Purinen oder eines Xanthinoxidase-Hemmers zur Herstellung eines Arzneimittels zur Behandlung von genetisch bedingten degenerativen Netzhauterkrankungen
JPH03106817A (ja)	1989-09-20	1991-05-07	Nippon Kayaku Co Ltd	アロプリノール製剤
JPH066700A (ja)	1992-06-22	1994-01-14	Fujitsu General Ltd	ハイビジョン受像機
GB9218711D0 (en)	1992-09-04	1992-10-21	Salim Aws S M	Skin cancer treatment
WO1994005293A1 (en)	1992-09-04	1994-03-17	Aws Shakir Mustafa Salim	Skin treatment compositions containing dimethylsulphone and allopurinol or oxypurinol
JP3106817B2 (ja)	1993-11-02	2000-11-06	富士電機株式会社	漏電遮断器
US6284234B1 (en) *	1998-08-04	2001-09-04	Johnson & Johnson Consumer Companies, Inc.	Topical delivery systems for active agents
US6060083A (en)	1999-04-01	2000-05-09	Topical Technologies, Inc.	Topical DMSO treatment for palmar-plantar erythrodysethesia
DE50112233D1 (de)	2000-06-20	2007-05-03	Henkel Kgaa	Verwendung von Vitamin B6-Derivaten zur Haarstrukturverbesserung
EP1343492B1 (en)	2000-11-22	2006-02-01	Rxkinetix, Inc.	Treatment of mucositis
US7544348B2 (en)	2001-02-15	2009-06-09	Access Pharmaceuticals, Inc.	Liquid formulations for the prevention and treatment of mucosal diseases and disorders
DK1455888T3 (da) *	2001-08-29	2009-08-24	Pharmakodex Ltd	Topisk indgivelsesindretning
CN1596111A (zh) *	2001-11-29	2005-03-16	桑得医药品公司	减轻化疗引起的不良效果的组合物及方法
DE10200578A1 (de) *	2002-01-09	2003-07-10	Roehm Gmbh	Haft- und Bindemittel für dermale oder transdermale Therapiesysteme
US6979688B2 (en)	2002-02-12	2005-12-27	Ford John P	Treatment method against side-effects of chemotherapy
US20040214215A1 (en) *	2003-03-07	2004-10-28	Yu Ruey J.	Bioavailability and improved delivery of alkaline pharmaceutical drugs
JP2007501864A (ja)	2003-06-11	2007-02-01	ノバセアインコーポレイティッド	活性ビタミンｄ化合物単独または他の治療薬との併用による、免疫介在疾患の治療法
CA2528359A1 (en)	2003-06-11	2004-12-23	Novacea, Inc.	Treatment of cancer with active vitamin d compounds in combination with radiotherapeutic agents and treatments
US20050148906A1 (en)	2003-12-24	2005-07-07	Gregory Skover	Apparatus for treatment of the skin having a signaling marker
JP2007526316A (ja) *	2004-03-01	2007-09-13	ルーメンセラピューティックスリミテッドライアビリティカンパニー	疾患を処置するための組成物および方法
JP4405326B2 (ja)	2004-06-28	2010-01-27	株式会社東芝	ランドリー機器
EP1796660B1 (en) *	2004-09-17	2016-11-23	BioMAS Ltd.	Use of ammonium trichloro(dioxyethylene-o,o')tellurate (as101) for the inhibition of interleukin-1beta-converting enzyme

2007
- 2007-05-31 DE DE602007004849T patent/DE602007004849D1/de active Active
- 2007-05-31 PL PL07729768T patent/PL2035006T3/pl unknown
- 2007-05-31 EP EP07729768A patent/EP2035006B1/en active Active
- 2007-05-31 WO PCT/EP2007/055367 patent/WO2007138103A1/en not_active Ceased
- 2007-05-31 PT PT07729768T patent/PT2035006E/pt unknown
- 2007-05-31 JP JP2009512609A patent/JP5028480B2/ja not_active Expired - Fee Related
- 2007-05-31 CA CA2654270A patent/CA2654270C/en not_active Expired - Fee Related
- 2007-05-31 ES ES07729768T patent/ES2341379T3/es active Active
- 2007-05-31 RS RSP-2010/0163A patent/RS51252B/sr unknown
- 2007-05-31 SI SI200730172T patent/SI2035006T1/sl unknown
- 2007-05-31 HR HR20100210T patent/HRP20100210T1/hr unknown
- 2007-05-31 MX MX2008015266A patent/MX2008015266A/es active IP Right Grant
- 2007-05-31 AT AT07729768T patent/ATE457729T1/de active
- 2007-05-31 AU AU2007267069A patent/AU2007267069B2/en not_active Ceased
- 2007-05-31 US US12/227,807 patent/US7973046B2/en not_active Expired - Fee Related
- 2007-05-31 NZ NZ573248A patent/NZ573248A/en not_active IP Right Cessation
- 2007-05-31 DK DK07729768.7T patent/DK2035006T3/da active
- 2007-05-31 RU RU2008152341/15A patent/RU2438673C2/ru not_active IP Right Cessation
2008
- 2008-11-24 IL IL195472A patent/IL195472A/en not_active IP Right Cessation
- 2008-12-31 KR KR1020087032168A patent/KR101471022B1/ko not_active Expired - Fee Related
2010
- 2010-03-23 CY CY20101100279T patent/CY1110336T1/el unknown
2011
- 2011-05-24 US US13/114,768 patent/US8557829B2/en not_active Expired - Fee Related
2012
- 2012-05-23 JP JP2012118062A patent/JP5389980B2/ja not_active Expired - Fee Related
2013
- 2013-09-09 US US14/021,723 patent/US20140011820A1/en not_active Abandoned
- 2013-10-09 JP JP2013211700A patent/JP2014028851A/ja active Pending

Also Published As

Publication number	Publication date
JP5028480B2 (ja)	2012-09-19
KR101471022B1 (ko)	2014-12-09
IL195472A (en)	2012-04-30
KR20090031697A (ko)	2009-03-27
AU2007267069B2 (en)	2011-08-11
US20140011820A1 (en)	2014-01-09
CA2654270A1 (en)	2007-12-06
JP5389980B2 (ja)	2014-01-15
JP2012180370A (ja)	2012-09-20
JP2009542581A (ja)	2009-12-03
DE602007004849D1 (de)	2010-04-01
CA2654270C (en)	2014-05-13
EP2035006A1 (en)	2009-03-18
US20110224237A1 (en)	2011-09-15
SI2035006T1 (sl)	2010-04-30
US7973046B2 (en)	2011-07-05
HRP20100210T1 (hr)	2010-05-31
RU2008152341A (ru)	2010-07-20
PT2035006E (pt)	2010-04-22
RS51252B (sr)	2010-12-31
US20090306097A1 (en)	2009-12-10
DK2035006T3 (da)	2010-04-19
JP2014028851A (ja)	2014-02-13
US8557829B2 (en)	2013-10-15
IL195472A0 (en)	2011-08-01
WO2007138103A1 (en)	2007-12-06
NZ573248A (en)	2011-01-28
CY1110336T1 (el)	2015-01-14
MX2008015266A (es)	2009-02-10
ATE457729T1 (de)	2010-03-15
RU2438673C2 (ru)	2012-01-10
ES2341379T3 (es)	2010-06-18
AU2007267069A1 (en)	2007-12-06
EP2035006B1 (en)	2010-02-17

Publication	Publication Date	Title
IL195472A0 (en)	2011-08-01	Use of allopurinol for the treatment of palmar plantar erythrodysesthesia
MY178634A (en)	2020-10-19	Topical formulation for a jak inhibitor
HK1216506A1 (zh)	2016-11-18	含硒組合物及其治療和預防與線粒體功能障礙有關的疾病或病症的應用
MY148688A (en)	2013-05-31	2-methylmorpholine pyrido-, pyrazo- and pyrimido-pyrimidine derivatives as mtor inhibitors
UA92000C2 (en)	2010-09-27	1-benzylindole-2-carboxamide derivatives
WO2011014255A8 (en)	2012-03-15	Treatment of crohn's disease with laquinimod
CL2013001136A1 (es)	2014-03-07	Un agente inhibitorio de la fosfodiesterasa 7 (pde7) para ser usado en el tratamiento o la reduccion de la posibilidad de una adiccion; y composicion farmaceutica, forma de dosificacion unitaria y kit farmaceutico que incluyen al inhibidor de fosfodiesterasa 7 (pde7) y un agente terapeutico adicional.
MY164730A (en)	2018-01-30	Aminoalcohol substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
MX2009004561A (es)	2009-05-11	Derivados de pirazolilo con actividad analgesica y utiles en el tratamiento o profilaxis del dolor.
SG150531A1 (en)	2009-03-30	Use of meloxicam for the treatment of respiratory diseases in pigs
WO2008006839A3 (en)	2008-07-31	Combinations of flibanserin with caffeine, process for their preparation and use thereof as medicaments
TW200722081A (en)	2007-06-16	New therapeutic combinations for the treatment or prevention of depression
WO2009041663A1 (ja)	2009-04-02	皮膚疾患の予防及び／または治療剤
MX2011011529A (es)	2012-02-08	Uso de alopurinol para el tratamiento de la reaccion cutanea en manos-pies.
MX2009005798A (es)	2009-08-12	Recuperacion de apoplejia.
WO2006102899A3 (en)	2006-12-28	Oxaprozin or closely related compound for the treatment and prevention of
WO2007144889A3 (en)	2008-06-19	Treatment of neurofibromatosis
WO2008100653A3 (en)	2009-12-30	Copper lowering treatment of cardiac disease
ZA201008022B (en)	2012-02-29	Pharmaceutical compositions for the treatment of warts
UA27836U (en)	2007-11-12	Method for treating community-acquired pneumonia of group 3 in adult patients
MX2009004627A (es)	2009-05-22	Uso de inhibidores de dipeptidil-peptidasa iv para prevenir, demorar, o reducir la presentacion de edema.
PL1817029T3 (pl)	2010-02-26	Pochodna izoksazolowa do łagodzenia bólu neuropatycznego
HK1186666A (en)	2014-03-21	Combination treatment for dermatological conditions
CY1114601T1 (el)	2016-10-05	Χρηση της αλλοπουρινολης για την αγωγη της δερματικης αντιδρασης χειρος-ποδος